EPIGRAL

Epigral Limited

Specialty chemicals maker of caustic-chlorine chain products, epichlorohydrin and CPVC

Commodities›Chemicals›Chemicals & Petrochemicals›Specialty Chemicals

epigral.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹995.80
Market cap
4,296 Cr
Stock P/E
15.9
P/B
1.93
Dividend yield
0.4%
ROE (FY26)
14.9%
ROCE (FY26)
14.8%
Operating margin (FY26)
15.8%
Debt / equity (FY26)
0.25
OCF / EBITDA (FY26)
76.8%
OCF / EBITDA (3Y)
72.4%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

Epigral (formerly Meghmani Finechem) makes caustic soda, chlorine and chemicals made from them, such as epichlorohydrin, CPVC (chlorinated polyvinyl chloride) resin and hydrogen peroxide, and sells mainly in India.

Company snapshot

29thBy market cap

Ranked among 68 companies in Specialty Chemicals.

What we see

Positives
  • ✓Debt-to-equity of 0.25x — the company is largely funded by its own money, not borrowed funds.

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales478 Cr472 Cr525 Cr651 Cr626 Cr645 Cr628 Cr607 Cr587 Cr597 Cr736 Cr705 Cr
Operating expenses (approx.)370 Cr349 Cr369 Cr475 Cr448 Cr463 Cr454 Cr443 Cr455 Cr494 Cr568 Cr526 Cr
EBITDA108 Cr123 Cr155 Cr176 Cr178 Cr183 Cr173 Cr163 Cr132 Cr103 Cr169 Cr179 Cr
OPM %22.6%26.0%29.6%27.1%28.5%28.3%27.6%26.9%22.5%17.2%22.9%25.4%
Other income1 Cr2 Cr2 Cr2 Cr6 Cr4 Cr3 Cr8 Cr2 Cr6 Cr-0.57 Cr4 Cr
Interest21 Cr20 Cr14 Cr14 Cr27 Cr-0.07 Cr12 Cr23 Cr22 Cr11 Cr16 Cr7 Cr
Depreciation32 Cr31 Cr30 Cr33 Cr32 Cr33 Cr34 Cr42 Cr42 Cr43 Cr42 Cr43 Cr
Profit before tax56 Cr74 Cr113 Cr131 Cr125 Cr154 Cr131 Cr107 Cr70 Cr55 Cr110 Cr134 Cr
Tax %32.1%33.6%31.9%34.4%35.1%32.5%33.8%-50.2%26.5%28.3%26.1%25.4%
Net profit38 Cr49 Cr77 Cr86 Cr81 Cr104 Cr87 Cr161 Cr51 Cr39 Cr81 Cr100 Cr
EPS (₹)₹9.14₹11.81₹18.60₹20.67₹19.57₹24.25₹20.14₹37.25₹11.87₹9.07₹18.76₹23.12

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales1,551 Cr2,188 Cr1,929 Cr2,550 Cr2,527 CrSign in free for the trailing twelve months
Operating expenses (approx.)1,041 Cr1,499 Cr1,448 Cr1,839 Cr1,960 CrSign in free for the trailing twelve months
EBITDA509 Cr689 Cr481 Cr711 Cr567 CrSign in free for the trailing twelve months
OPM %32.9%31.5%24.9%27.9%22.4%Sign in free for the trailing twelve months
Other income4 Cr8 Cr7 Cr15 Cr15 CrSign in free for the trailing twelve months
Interest44 Cr66 Cr73 Cr53 Cr72 CrSign in free for the trailing twelve months
Depreciation86 Cr109 Cr124 Cr133 Cr168 CrSign in free for the trailing twelve months
Profit before tax383 Cr522 Cr291 Cr541 Cr341 CrSign in free for the trailing twelve months
Tax %34.1%32.4%32.6%33.9%2.6%Sign in free for the trailing twelve months
Net profit253 Cr353 Cr196 Cr358 Cr332 CrSign in free for the trailing twelve months
EPS (₹)₹60.84₹85.03₹47.13₹84.68₹76.95Sign in free for the trailing twelve months
Dividend payout %0.0%6.9%5.3%8.8%5.5%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital42 Cr42 Cr42 Cr43 Cr43 Cr
Reserves684 Cr1,028 Cr1,213 Cr1,861 Cr2,178 Cr
Borrowings989 Cr876 Cr963 Cr585 Cr563 Cr
Other liabilities408 Cr487 Cr578 Cr663 Cr721 Cr
Total liabilities2,124 Cr2,432 Cr2,794 Cr3,152 Cr3,505 Cr
Fixed assets (net)1,039 Cr1,779 Cr1,745 Cr2,219 Cr2,102 Cr
CWIP589 Cr158 Cr483 Cr64 Cr451 Cr
Investments0 Cr21 Cr21 Cr98 Cr23 Cr
Loans & advances0.23 Cr0.14 Cr0.48 Cr0.39 Cr0.35 Cr
Inventories154 Cr212 Cr263 Cr388 Cr349 Cr
Trade receivables256 Cr166 Cr179 Cr232 Cr417 Cr
Cash & bank25 Cr14 Cr3 Cr19 Cr5 Cr
Other assets59 Cr82 Cr101 Cr132 Cr159 Cr
Total assets2,124 Cr2,432 Cr2,794 Cr3,152 Cr3,505 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity284 Cr626 Cr398 Cr441 Cr436 Cr
Cash from investing-455 Cr-437 Cr-401 Cr-262 Cr-355 Cr
Cash from financing195 Cr-200 Cr-8 Cr-164 Cr-94 Cr
Net cash flow24 Cr-11 Cr-11 Cr15 Cr-14 Cr
Free cash flow (OCF − Capex)-172 Cr210 Cr-0.79 Cr246 Cr41 Cr

Ratios

MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %24.9%30.2%16.4%23.9%14.8%
ROE %34.8%33.0%15.6%18.8%14.9%
Debtor days6028343360
Inventory days74649010785
Days payable4233565163
Cash conversion cycle9258678982
OCF / EBITDA %55.7%90.9%82.6%62.0%76.8%
OCF / EBITDA % (3 years)——77.9%77.9%72.4%
Debt / equity1.360.820.770.310.25
Current ratio0.840.650.641.571.16
Net debt / EBITDA1.891.251.990.800.98